EurekaMag.com logo
+ Translate

Investigation of some relationships between administration of 4G- beta -D-galactosylsucrose (Lactosucrose, LS) and abdominal symptoms - Measurement of maximum non-effective dose


, : Investigation of some relationships between administration of 4G- beta -D-galactosylsucrose (Lactosucrose, LS) and abdominal symptoms - Measurement of maximum non-effective dose. Denpun Kagaku = Journal for Starch and its Related Carbohydrates and Enzymes 40(1): 15-19

LS is synthesized from sucrose + lactose using a beta -fructofuranosidase; it is slightly hydrolysed by mammalian digestive systems and is readily utilized by the bifidobacteria predominating in the human intestine. Effects of up to 0.8 g LS/kg bodyweight on faecal condition and abdominal symptoms were studied in 38 male and 46 female healthy volunteers.

(PDF 0-2 workdays service)

Accession: 002416881

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Oku, K.; Kasagi, T.; Sawatani, I.; Fukuda, S.; Kurimoto, M., 2002: Effect of administration of 4G- beta -D-galactosylsucrose (lactosucrose) on abdominal symptoms in lactose-intolerant subjects. The effect of administration of 4G- beta -D-galactosylsucrose (lactosucrose: LS) on breath hydrogen excretion and abdominal symptoms after ingestion of lactose were investigated. Ten lactose-intolerant volunteers were administrated 5 g of LS daily...

Teramoto, F.; Rokutan, K.; Sugano, Y.; Oku, K.; Kishino, E.; Fujita, K.; Hara, K.; Kishi, K.; Fukunaga, M.; Morita, T., 2006: Long-term administration of 4G-beta-D-galactosylsucrose (lactosucrose) enhances intestinal calcium absorption in young women: a randomized, placebo-controlled 96-wk study. This study determined the effect of tong-term administration of 4(G)-O-D-galactosylsucrose (lactosucrose: LS) on intestinal calcium absorption. In a randomized, single-blind. parallel-group study, LS (n=9, 6.0 g twice daily) or a placebo (maltose;...

Anonymous, 2007: Effects of dietary lactosucrose (4(G)-beta-D-galactosylsucrose) on the

Fujita, K.; Ogata, Y.; Hara, K.; Terada, A.; Hara, H.; Mitsuoka, T., 1995: Effect of 4 G- beta -D-galactosylsucrose (lactosucrose) on intestinal flora. Lactosucrose (LS) [4-( beta -D-galactosyl)sucrose], underwent hardly any hydrolysis in vitro under conditions representing the human digestive system. No significant change was observed in blood glucose or serum insulin in normal adults after inge...

Fujii, C.; Kumemura, M.; Hashimoto, F.; Ishida, S.; Matsuo, K.; Kimura, H.; Miyazoe, R.; Okamatsu, H.; Mitsuoka, T., 1992: Effect of 4G- beta -D- galactosylsucrose (lactosucrose) on human fecal flora. 2 experiments were carried out in vitro and in vivo in order to determine physiological properties of 4G- beta -D- galactosylsucrose (lactosucrose: LS) as a bifidus factor. The effects of LS supplement on short chain fatty acids (SCFA) production,...

Taniguchi, Y.; Mizote, A.; Kohno, K.; Iwaki, K.; Oku, K.; Chaen, H.; Fukuda, S., 2007: Effects of dietary lactosucrose (4G-beta-D-galactosylsucrose) on the IgE response in mice. In this study, we examined the effects of dietary lactosucrose (LS, a non-digestible oligosaccharide) on the IgE response in mice immunized with ovalbumin (OVA)/alum. In addition to IgG1 and IgG2a responses, the anti-OVA IgE response in mice fed L...

Fujita, K.; Hara, K.; Nakayama, S.; Nishikawa, M.; Tuchiya, T.; Mashiko, S., 1999: Effects of 4G- beta -D-galactosylsucrose (lactosucrose) on bone in weanling rats. Feed containing 0.7% 4G- beta -D-galactosylsucrose (lactosucrose, LS), a non-digestible oligosaccharide, was given to weanling rats aged 4 to 12 weeks to investigate the effects of LS ingestion on bone. During the test period of ingestion, the qua...

Han LiKun; L.J.ng; Sumiyoshi, M.; Tsujita, T.; Kimura, Y.; Zheng YiNan; Okuda, H., 1999: Reduction in fat storage during 4G- beta -D-galactosylsucrose (lactosucrose) treatment in mice fed a high-fat diet. Lactosucrose (4G- beta -D-galactosylsucrose) was found to inhibit the absorption of 2-mono-oleoylglycerol by rat brush border membrane vesicles, and to reduce plasma triacylglycerol levels previously elevated by oral administration of a lipid emul...

Yoneyama, M.; Mandai, T.; Aga, H.; Fujii, K.; Sakai, S.; Katayama, Y., 1992: Effects of 4G- beta -D-galactosylsucrose (lactosucrose) intake on intestinal flora in healthy humans. Purified lactosucrose (LS-98), a poorly digestible oligosaccharide, 10, 5 or 20 g/day was given orally to healthy subjects for 7 and 14 days, respectively. Daily faecal weights and faecal moisture contents were not affected by the administration o...

Teramoto, F.; Rokutan, K.; Kawakami, Y.; Fujimura, Y.; Uchida, J.; Oku, K.; Oka, M.; Yoneyama, M., 1996: Effect of 4G-beta-D-galactosylsucrose (lactosucrose) on fecal microflora in patients with chronic inflammatory bowel disease. Metabolic interaction between the intestinal microflora and the host has been suggested to play a role in the pathogenesis of chronic inflammatory bowel disease. Elemental or low-fat, low-residual diets in patients with Crohn's disease or ulc...